We are live on ! Find out more
IHE icon

iShares US Pharmaceuticals ETF
IHE

63 hedge funds and large institutions have $157M invested in iShares US Pharmaceuticals ETF in 2013 Q3 according to their latest regulatory filings, with 7 funds opening new positions, 27 increasing their positions, 18 reducing their positions, and 7 closing their positions.

New
Increased
Maintained
Reduced
Closed

50% more repeat investments, than reductions

Existing positions increased: 27 | Existing positions reduced: 18

0% more funds holding

Funds holding: 63 → 63 (0)

0% more funds holding in top 10

Funds holding in top 10: 1 → 1 (0)

0% more first-time investments, than exits

New positions opened: 7 | Existing positions closed: 7

5% less capital invested

Capital invested by funds: $164M → $157M (-$7.67M)

12.55% less ownership

Funds ownership: 107.64% → 95.09% (-13%)

Holders
63
Holders Change
–
Holders Change %
0%
% of All Funds
2.04%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.03%
New
7
Increased
27
Reduced
18
Closed
7
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

1
RJFSA
Raymond James Financial Services Advisors
Florida
+$4.94M
2
Wells Fargo
Wells Fargo
California
+$1.87M
3
Morgan Stanley
Morgan Stanley
New York
+$838K
4
SG Americas Securities
SG Americas Securities
New York
+$750K
5
Brown Advisory
Brown Advisory
Maryland
+$413K

Top Sellers

1
Fidelity Investments
Fidelity Investments
Massachusetts
-$9.83M
2
CCMG
Clark Capital Management Group
Pennsylvania
-$6.13M
3
Rafferty Asset Management
Rafferty Asset Management
New York
-$5.77M
4
Susquehanna International Group
Susquehanna International Group
Pennsylvania
-$2.72M
5
Bank of America
Bank of America
North Carolina
-$1.84M
Name Holding Trade Value Shares
Change 		Change in
Stake
Morgan Stanley
1
Morgan Stanley
New York
$31.1M +$838K +23,799 +3%
Bank of America
2
Bank of America
North Carolina
$22.8M -$1.84M -52,203 -8%
Wells Fargo
3
Wells Fargo
California
$14.5M +$1.87M +53,088 +15%
BCI
4
Brinker Capital Investments
Pennsylvania
$10.2M +$127K +3,600 +1%
Brown Advisory
5
Brown Advisory
Maryland
$8.08M +$413K +11,730 +5%
Royal Bank of Canada
6
Royal Bank of Canada
Ontario, Canada
$7.53M +$57.3K +1,626 +0.8%
RJFSA
7
Raymond James Financial Services Advisors
Florida
$6.48M +$4.94M +140,262 +330%
SFI
8
SPC Financial Inc
Maryland
$6.42M -$259K -7,350 -4%
MCM
9
Murphy Capital Management
New Jersey
$4.7M -$154K -4,362 -3%
PAMU
10
Pictet Asset Management (UK)
United Kingdom
$4.59M – – –
ST
11
Spinnaker Trust
Maine
$4.51M +$317K +9,003 +8%
U
12
UBS
Switzerland
$3.7M +$217K +6,171 +6%
LPL Financial
13
LPL Financial
California
$3.65M +$194K +5,502 +6%
RJA
14
Raymond James & Associates
Florida
$2.94M -$284K -8,055 -9%
Bank of Montreal
15
Bank of Montreal
Ontario, Canada
$2.92M +$123K +3,495 +4%
EC
16
Estate Counselors
Wisconsin
$1.98M -$46.5K -1,320 -2%
PAG
17
Pinnacle Advisory Group
Maryland
$1.83M -$46.5K -1,320 -2%
Commonwealth Equity Services
18
Commonwealth Equity Services
Massachusetts
$1.81M -$67.8K -1,926 -4%
PP
19
Patten & Patten
Tennessee
$1.46M +$155K +4,395 +12%
DADC
20
D.A. Davidson & Co
Montana
$1.24M -$24.1K -684 -2%
Susquehanna International Group
21
Susquehanna International Group
Pennsylvania
$1.24M -$2.72M -77,247 -69%
SNC
22
Stifel Nicolaus & Co
Missouri
$998K -$220K -6,258 -18%
AIG
23
American International Group
New York
$943K +$8.77K +249 +0.9%
SG Americas Securities
24
SG Americas Securities
New York
$756K +$750K +21,309 New
SI
25
SII Investments
Wisconsin
$745K +$21.1K +600 +3%
1
2 3

IHE Hedge Fund Activity: Q3 2013 in Review

63 of the 3,084 institutional investors tracked by Wall St. Rank reported a position in iShares US Pharmaceuticals ETF (IHE) for Q3 2013, worth a combined $157M — down 4.7% from $164M a quarter earlier.

Fund positioning in IHE was balanced in Q3 2013: 7 funds opened new positions, 7 closed out, 27 added to existing stakes and 18 trimmed.

The largest buyer was Raymond James Financial Services Advisors, adding an estimated $4.94M. The largest seller was Fidelity Investments, exiting entirely with an estimated $9.83M sold.

  • 63 institutional investors held iShares US Pharmaceuticals ETF (IHE) as of Q3 2013, unchanged from Q2 2013.
  • Funds reported $157M of iShares US Pharmaceuticals ETF stock for Q3 2013, down 4.7% quarter-over-quarter.
  • 7 funds opened new iShares US Pharmaceuticals ETF positions in Q3 2013 and 7 closed out, a net change of 0 holders.
  • The largest iShares US Pharmaceuticals ETF buyer in Q3 2013 was Raymond James Financial Services Advisors, an estimated $4.94M added.
  • The largest iShares US Pharmaceuticals ETF seller in Q3 2013 was Fidelity Investments, an estimated $9.83M sold.

Based on aggregated 13F filings for Q3 2013.